Status
Conditions
Treatments
About
The purpose of this study is to evaluate the impact of 28-day supplementation with high-dose human recombinant lactoferrin, low-dose human recombinant lactoferrin, and an active control product formulated with bovine lactoferrin on indicators of immunity in healthy males and females.
Full description
Samples will be retained for possible analyses such as lactoferrin absorption, distribution, metabolism, and excretion (ADME) and gut microbiota.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
66 participants in 3 patient groups
Loading...
Central trial contact
Caryn Adams, MPH; Liana Guarneiri, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal